Nantahala Capital Management LLC Trims Stock Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Nantahala Capital Management LLC reduced its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 29.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,654,470 shares of the company's stock after selling 704,671 shares during the quarter. Establishment Labs accounts for 3.3% of Nantahala Capital Management LLC's investment portfolio, making the stock its 3rd biggest holding. Nantahala Capital Management LLC owned about 5.91% of Establishment Labs worth $76,221,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Capital Research Global Investors raised its stake in Establishment Labs by 29.3% during the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock valued at $88,064,000 after purchasing an additional 433,484 shares during the period. William Blair Investment Management LLC increased its stake in shares of Establishment Labs by 44.1% in the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock worth $37,447,000 after acquiring an additional 248,888 shares during the last quarter. Boothbay Fund Management LLC increased its stake in shares of Establishment Labs by 68.8% in the fourth quarter. Boothbay Fund Management LLC now owns 525,248 shares of the company's stock worth $24,198,000 after acquiring an additional 214,119 shares during the last quarter. Voya Investment Management LLC increased its stake in shares of Establishment Labs by 7,249.5% in the fourth quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock worth $18,809,000 after acquiring an additional 402,707 shares during the last quarter. Finally, Assenagon Asset Management S.A. acquired a new position in shares of Establishment Labs in the fourth quarter worth $12,898,000. 72.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on ESTA shares. Needham & Company LLC started coverage on shares of Establishment Labs in a research note on Monday, April 14th. They issued a "hold" rating on the stock. Stephens reaffirmed an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, Establishment Labs has a consensus rating of "Moderate Buy" and a consensus target price of $57.40.

Establishment Labs Trading Up 2.3 %

Shares of ESTA traded up $0.69 during trading hours on Thursday, hitting $31.04. 363,388 shares of the stock traded hands, compared to its average volume of 459,636. Establishment Labs Holdings Inc. has a 1-year low of $26.56 and a 1-year high of $60.12. The business has a fifty day moving average of $35.80 and a 200-day moving average of $39.02. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The firm has a market capitalization of $895.38 million, a PE ratio of -12.03 and a beta of 0.77.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $44.51 million during the quarter, compared to analyst estimates of $44.45 million. Analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.